TIS for Drug Resistant TLE
NCT: NCT07519018 · NOT_YET_RECRUITING
Brief Summary
Temporal interference (TI) stimulation is a new neuromodulation method. Compared with traditional neuromodulation therapy, TI has deep targeting and focusing, and it has been confirmed to modulate sleep, cognition, and movement disorders. Recent study shown that TI stimulation targeting the hippocampus could significantly reduce epileptiform discharges, but its efficacy on seizures was still unclear. Therefore, the aim of this study is to observe the therapeutic effect of TI stimulation targeting the hippocampus in patients with refractory temporal lobe epilepsy (TLE) for 5 days, and to provide support for clinical trials of non-invasive treatment of refractory TLE.
Frequently Asked Questions
What is TIS for Drug Resistant TLE?
TIS for Drug Resistant TLE is a clinical trial registered under NCT07519018. Current status: NOT_YET_RECRUITING.
What is the status of NCT07519018?
The current status of NCT07519018 (TIS for Drug Resistant TLE) is: NOT_YET_RECRUITING.
When did TIS for Drug Resistant TLE start?
TIS for Drug Resistant TLE started on 2026-04-15.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.